Using the strength of drug discovery and clinical development in the above therapeutic area, the client strives to further strengthen its product lineup and pipeline.
Rare diseases are a therapeutic area in which unmet medical needs and a demand for new drug discovery are high. Therefore, the client has issued this open request to accelerate clinical application of new drugs in collaboration with external organizations that have developed a potential candidate compound.
Drug candidates for rare diseases in general are eligible. Target diseases include, but are not limited to, the following:
- Neurological diseases
- Cardiovascular diseases
- Muscle diseases
- Autoimmune diseases
However, drugs for cancer, blood diseases, infectious diseases, and ophthalmic diseases are excluded.